24 /100
LOW RISK
Score updated May 29, 2026

BLIN — Bridgeline Digital, Inc. Dilution Risk Tracker

Track BLIN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BLIN — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
22
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
46%
📜 Warrant Exercise 60%
• Massive warrant overhang: 56% of shares outstanding
• Warrant risk score very high (90/100)
🔄 Reverse Split 55%
• 50-day avg $0.92 below $1 exchange minimum
🔔 Track BLIN — Get forecast alerts →

💹 Market Data

Market Cap$15.12M
Shares Outstanding12.60M
Float10.17M
Cash$1.37M
Debt$665.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 2.4% shares (2025Q4 vs prior)
19 institutional holders · 1.89M shares
#1 BARD ASSOCIATES INC 1.16M shares
#2 RENAISSANCE TECHNOLOGIES LLC 146.1K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 126.0K shares
+ 16 more holders Sign up free to view →

📉 Short Interest

Short Interest6.5K
Days to Cover1.0
% of Float0.1%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Sep 30, 2025
xbrl XBRL CONVERTIBLE Jun 30, 2019
4 INSIDER TRANSACTION Mar 16, 2026
4 INSIDER TRANSACTION Mar 16, 2026
4 INSIDER TRANSACTION Mar 16, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track BLIN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BLIN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for BLIN
📊 BLIN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BLIN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.